urolithin a

Small moleculeexperimental

Clinical trial activity

11 trials · 13 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Nov 8, 2019 (NCT04160312)

Timeline

2020s

  1. Jan 1, 2024

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07231783N/ANov 15, 2025Amazentis SA, Atlantia Food Clinical Trials
NCT07161310N/ASep 30, 2025Amazentis SA, Georg-Speyer-Haus, J. W. Goethe University
NCT06990256N/ASep 1, 2025Abinopharm, Inc, Huazhong University of Science and Technology
NCT06274749N/ANov 17, 2024National Institute on Aging (NIA)
NCT06022822Phase 2Feb 17, 2024Cedars-Sinai Medical Center, National Cancer Institute (NCI)
NCT05921266N/ADec 31, 2023University of Oklahoma
NCT05735886N/AJan 30, 2023Amazentis SA, J. W. Goethe University
NCT05079607N/AOct 4, 2021Amazentis SA, Princeton Research Corporation
NCT04985630N/AAug 30, 2021Amazentis SA
NCT04783207N/AApr 21, 2021Amazentis SA, Australian Catholic University
NCT04160312N/ANov 8, 2019Amazentis SA, Atlantia Food Clinical Trials, Rush University
Showing 11 of 11 trials
Page 1 / 1

Organizations

Research & Development (13)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Amazentis SAFor profit7612019
Atlantia Food Clinical TrialsFor profit2012019
J. W. Goethe UniversityAcademic/Hospital2112023
Abinopharm, IncFor profit1012025
Australian Catholic UniversityAcademic/Hospital1012021
Cedars-Sinai Medical CenterAcademic/Hospital1012024
Georg-Speyer-HausAcademic/Hospital1012025
Huazhong University of Science and TechnologyAcademic/Hospital1112025
National Cancer Institute (NCI)Government1112024
National Institute on Aging (NIA)Government1112024
Princeton Research CorporationFor profit1012021
Rush UniversityAcademic/Hospital1012019
University of OklahomaAcademic/Hospital1112023
13 organizations
Page 1 / 1